PP
ELOS

PDT Partners’s Syneron Medical Ltd ELOS Stock Holding History

PDT Partners’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-111,476
Closed -$1.18M – 617
2017
Q1 		$1.18M Buy
111,476
+90,785
+439% +$878K 0.06% 297
2016
Q4 		$174K Buy
20,691
+5,500
+36% +$43.1K 0.01% 474
2016
Q3 		$109K Buy
15,191
+3,400
+29% +$23.6K 0.01% 459
2016
Q2 		$91K Sell
11,791
-5,600
-32% -$39.9K 0.01% 434
2016
Q1 		$127K Hold
17,391
– – 0.01% 535
2015
Q4 		$134K Buy
17,391
+43
+0.2% +$328 0.02% 367
2015
Q3 		$124K Sell
17,348
-494
-3% -$4.75K ﹤0.01% 1203
2015
Q2 		$189K Sell
17,842
-9,895
-36% -$116K ﹤0.01% 1248
2015
Q1 		$343K Buy
+27,737
New +$307K 0.01% 1124
2014
Q2 		– Sell
-15,654
Closed -$195K – 1791
2014
Q1 		$195K Buy
+15,654
New +$185K ﹤0.01% 1235

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

PDT Partners's ELOS Position: Q2 2017 in Review

PDT Partners sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 111,476 shares — an estimated $1.18M sold.

PDT Partners first reported a position in ELOS in Q1 2014 and held it in 10 quarters. The position peaked at $1.18M in Q1 2017. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • PDT Partners reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • PDT Partners sold 111,476 Syneron Medical Ltd shares in Q2 2017, an estimated $1.18M.
  • PDT Partners first reported a position in Syneron Medical Ltd in Q1 2014 and held it in 10 quarters.
  • PDT Partners's Syneron Medical Ltd position peaked at $1.18M in Q1 2017.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on PDT Partners's 13F filing for Q2 2017, filed 14 Aug 2017.